Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Syros Pharmaceuticals, Inc.

Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome
From Syros Pharmaceuticals, Inc.
Via Business Wire
Tickers SYRS
Syros Announces Closing of Merger with Tyme Technologies and Concurrent Private Placement
From Syros Pharmaceuticals, Inc.
Via Business Wire
Tickers SYRS
Syros and Tyme Technologies Announce Stockholder Approval of Merger
From Syros Pharmaceuticals, Inc.
Via Business Wire
Tickers SYRS TYME
Syros Receives FDA Orphan Drug Designation for SY-5609 for the Treatment of Pancreatic Cancer
From Syros Pharmaceuticals, Inc.
Via Business Wire
Tickers SYRS
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.